In contrast, prostate cancer tissues exhibited frequent deep deletions in ABCG2, ABCG1, ABCC4, ABCA2, ABCC2, ABCC7/CFTR, and ABCC9 (Figures 3b and 5). This evidence concerns the gene ABCA2 and prostate carcinoma.